15 results
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
- Pharmacology Summary ... : Weight gain, Hypoglycemia ... #Pharmacology #Summary ... #DM2 #diabetes ... #endocrinology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology Summary ... Does not cause hypoglycemia ... #Pharmacology #Summary ... #DM2 #diabetes ... #endocrinology
Summary and links to five landmark trials of intensive control vs standard therapy in DM2:

 UKPDS
Summary and links ... standard therapy in DM2 ... VisualAbstract #Endocrinology ... PrimaryCare #Diabetes #DM2
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications Summary ... comparison #management #endocrinology ... #dm2
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS)
Absolute Insulin deficit:
 - Type I DM:
deficit: - Type I DM ... produced - Type II DM ... food binges, etc Hyperglycemia ... pathophysiology #comparison #endocrinology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology Summary ... mL/minute/1.73 m2 ... #Pharmacology #Summary ... #DM2 #diabetes ... #endocrinology
Causes of Provoked Pediatric Seizures - Differential Diagnosis Algorithm - "DIMS" Mnemonic
Drugs:
 • Drug overdose
 •
Algorithm - "DIMS" Mnemonic ... Metabolic: • Hypoglycemia ... • Hyperglycemia ... Syndrome #DIMS #Mnemonic ... Algorithm #Causes #Peds
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology Summary ... #Pharmacology #Summary ... #DM2 #diabetes ... #endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology Summary ... #Pharmacology #Summary ... #DM2 #diabetes ... #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
minimal chance of hypoglycemia ... Management #Diabetes #DM2 ... #Endocrinology